ROIV: Epperly Melissa B, discloses a sale
By AlphaYouPublished Form 4
Epperly Melissa B,
Reporting filer
Epperly Melissa B, reported Sale in Roivant Sciences Ltd.: 4338 units of Common Shares, dated 2026-09-15. The full Form 4 contains 2 transaction entries.
- Disclosed
- Sep 17, 2026
Reported details
2 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Epperly Melissa B, | 2026-09-15 | S | Sale | 4338 | 39.65 | 10,500 | 2 days | Filed terms
|
| Common Shares | Epperly Melissa B, | 2026-09-15 | S | Sale | 600 | 40.38 | 9,900 | 2 days | Filed terms
|
Common Shares
- Owner
- Epperly Melissa B,
- Date
- 2026-09-15
- Code
- S
- Action
- Sale
- Quantity
- 4338
- Price
- 39.65
- Following holdings
- 10,500
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Shares
- transaction Date: 2026-09-15
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- transaction Shares: 4338
- transaction Price Per Share: 39.65
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 10500
- id: F1
- direct Or Indirect Ownership: D
Common Shares
- Owner
- Epperly Melissa B,
- Date
- 2026-09-15
- Code
- S
- Action
- Sale
- Quantity
- 600
- Price
- 40.38
- Following holdings
- 9,900
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Shares
- transaction Date: 2026-09-15
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- transaction Shares: 600
- transaction Price Per Share: 40.38
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 9900
- id: F2
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Epperly Melissa B,: Director.
- The filing reports a Rule 10b5-1 trading plan.
- F1: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.25 to $40.15, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on March 30, 2026.
- F2: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.25 to $40.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on March 30, 2026.
Original sources
Prepared automatically from public filing data. Report a correction.